China shares slip on GDP data; Hong Kong edges lower
* HSI -0.3 pct, H-shares -0.3 pct, CSI300 -0.4 pct
* Little impact from China GDP data
* Investors still expect more government support policies
By Chen Yixin and Kazunori Takada
SHANGHAI, Oct 21 (Reuters) - China shares eased on Tuesday, with pharmaceutical and property sectors hit by profit-taking and weak economic data, but losses were limited on optimism the government will roll out more policies to help industry amid a slowing economy.
Third-quarter growth data, which came in slightly better than expectations although at a six-year low, had little impact on the market, analysts said. ID:nB9N0RQ01A]
"In China, the economic environment is not the only factor driving the market. Other issues, such as government policies, are also significant for the market," said Du Changchun, analyst at Northeast Securities in Shanghai.
The Shanghai Composite Index fell 0.3 percent to 2,350.4 points by midday. The CSI300 of the leading Shanghai and Shenzhen A-share listings also declined 0.4 percent.
Pharmaceutical stocks, which were the biggest outperformers on Monday, were main drags for the index due to profit-taking. Shenzhen Neptunus Bioengineering Co Ltd dropped 4.4 percent and Da An Gene Co Ltd slumped 5.2 percent. Continuación...